Evidence map›Paper›PMID 34131106›Full record

ArticleCell death & disease2021

ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1.

Fang Wu, Weifeng Huang, Qin Tan, Yong Guo, Yongmei Cao, Jiawei Shang, Feng Ping, Wei Wang, Yingchuan Li

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Biomolecules · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. WTAP-mediated mJournal of translational medicine · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fang WuDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Weifeng Huang *Department of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Qin Tan *Department of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Yong GuoDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Yongmei CaoDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Jiawei ShangDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Feng PingDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China.
Wei WangDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China. Drwangwei3037@126.com.
Yingchuan LiDepartment of Critical Care Medicine, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 200233, Shanghai, China. yingchuan.li@sjtu.edu.cn.ORCID 0000-0002-5522-4402
Shanghai Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among several leading cardiovascular disorders, ischemia-reperfusion (I/R) injury causes severe manifestations including acute heart failure and systemic dysfunction. Recently, there has been increasing evidence suggesting that alterations in mitochondrial morphology and dysfunction also play an important role in the prognosis of cardiac disorders. Long non-coding RNAs (lncRNAs) form major regulatory networks altering gene transcription and translation. While the role of lncRNAs has been extensively studied in cancer and tumor biology, their implications on mitochondrial morphology and functions remain to be elucidated. In this study, the functional roles of Zinc finger protein 36-like 2 (ZFP36L2) and lncRNA PVT1 were determined in cardiomyocytes under hypoxia/reoxygenation (H/R) injury in vitro and myocardial I/R injury in vivo. Western blot and qRT-PCR analysis were used to assess the levels of ZFP36L2, mitochondrial fission and fusion markers in the myocardial tissues and cardiomyocytes. Cardiac function was determined by immunohistochemistry, H&E staining, and echocardiogram. Ultrastructural analysis of mitochondrial fission was performed using transmission electron microscopy. The mechanistic model consisting of PVT1 with ZFP36L2 and microRNA miR-21-5p with E3 ubiquitin ligase MARCH5 was assessed by subcellular fraction, RNA pull down, FISH, and luciferase reporter assays. These results identified a novel regulatory axis involving PVT1, miR-21-5p, and MARCH5 that alters mitochondrial morphology and function during myocardial I/R injury. Using an in vivo I/R injury mouse model and in vitro cardiomyocytes H/R model, we demonstrated that ZFP36L2 directly associates with PVT1 and alters mitochondrial fission and fusion. PVT1 also interactes with miR-21-5p and suppresses its expression and activity. Furthermore, we identified MARCH5 as a modifier of miR-21-5p, and its effect on mitochondrial fission and fusion are directly proportional to PVT1 expression during H/R injury. Our findings show that manipulation of PVT1-miR-21-5p-MARCH5-mediated mitochondrial fission and fusion via ZFP36L2 may be a novel therapeutic approach to regulate myocardial I/R injury.

Indexed as

AnimalsCells, CulturedHeart FailureMaleMiceMice, Inbred C57BLMitochondrial DynamicsMyocardial Reperfusion InjuryMyocytes, CardiacRNA, Long NoncodingTristetraprolinPVT1 long-non-coding RNA, mouseRNA, Long NoncodingTristetraprolinZfp36 protein, mouse

Identifiers

PMID34131106
PMCPMC8206151
OpenAlexW3170593364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.